Logo image of SYPR

SYPRIS SOLUTIONS INC (SYPR) Stock Fundamental Analysis

NASDAQ:SYPR - US8716551069 - Common Stock

1.86 USD
+0.03 (+1.64%)
Last: 8/22/2025, 8:00:00 PM
1.87 USD
+0.01 (+0.54%)
After Hours: 8/22/2025, 8:00:00 PM
Fundamental Rating

1

Overall SYPR gets a fundamental rating of 1 out of 10. We evaluated SYPR against 80 industry peers in the Automobile Components industry. SYPR may be in some trouble as it scores bad on both profitability and health. SYPR does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

SYPR had negative earnings in the past year.
In the past year SYPR has reported a negative cash flow from operations.
In multiple years SYPR reported negative net income over the last 5 years.
SYPR had a positive operating cash flow in 4 of the past 5 years.
SYPR Yearly Net Income VS EBIT VS OCF VS FCFSYPR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M -10M -20M

1.2 Ratios

SYPR's Return On Assets of -2.29% is on the low side compared to the rest of the industry. SYPR is outperformed by 77.50% of its industry peers.
With a Return On Equity value of -12.79%, SYPR is not doing good in the industry: 80.00% of the companies in the same industry are doing better.
SYPR has a Return On Invested Capital of 2.59%. This is amonst the worse of the industry: SYPR underperforms 80.00% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for SYPR is significantly below the industry average of 8.62%.
Industry RankSector Rank
ROA -2.29%
ROE -12.79%
ROIC 2.59%
ROA(3y)-1.68%
ROA(5y)0.28%
ROE(3y)-9.48%
ROE(5y)-0.38%
ROIC(3y)2.71%
ROIC(5y)2.33%
SYPR Yearly ROA, ROE, ROICSYPR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -50 -100

1.3 Margins

The Operating Margin of SYPR (1.13%) is worse than 80.00% of its industry peers.
In the last couple of years the Operating Margin of SYPR has grown nicely.
SYPR has a worse Gross Margin (12.91%) than 83.75% of its industry peers.
In the last couple of years the Gross Margin of SYPR has grown nicely.
Industry RankSector Rank
OM 1.13%
PM (TTM) N/A
GM 12.91%
OM growth 3Y2.33%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.59%
GM growth 5Y4.73%
SYPR Yearly Profit, Operating, Gross MarginsSYPR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 -20

More info and screens

1

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so SYPR is destroying value.
The number of shares outstanding for SYPR has been increased compared to 1 year ago.
Compared to 5 years ago, SYPR has more shares outstanding
SYPR has a worse debt/assets ratio than last year.
SYPR Yearly Shares OutstandingSYPR Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M
SYPR Yearly Total Debt VS Total AssetsSYPR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M

2.2 Solvency

SYPR has an Altman-Z score of 0.21. This is a bad value and indicates that SYPR is not financially healthy and even has some risk of bankruptcy.
SYPR's Altman-Z score of 0.21 is on the low side compared to the rest of the industry. SYPR is outperformed by 88.75% of its industry peers.
A Debt/Equity ratio of 0.61 indicates that SYPR is somewhat dependend on debt financing.
The Debt to Equity ratio of SYPR (0.61) is worse than 75.00% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.61
Debt/FCF N/A
Altman-Z 0.21
ROIC/WACC0.29
WACC8.98%
SYPR Yearly LT Debt VS Equity VS FCFSYPR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M -10M 20M -20M

2.3 Liquidity

SYPR has a Current Ratio of 1.37. This is a normal value and indicates that SYPR is financially healthy and should not expect problems in meeting its short term obligations.
With a Current ratio value of 1.37, SYPR is not doing good in the industry: 86.25% of the companies in the same industry are doing better.
A Quick Ratio of 0.42 indicates that SYPR may have some problems paying its short term obligations.
Looking at the Quick ratio, with a value of 0.42, SYPR is doing worse than 96.25% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.37
Quick Ratio 0.42
SYPR Yearly Current Assets VS Current LiabilitesSYPR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M

More info and screens

2

3. Growth

3.1 Past

SYPR shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 44.51%, which is quite impressive.
SYPR shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -25.92%.
SYPR shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 9.78% yearly.
EPS 1Y (TTM)44.51%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
Revenue 1Y (TTM)-25.92%
Revenue growth 3Y12.9%
Revenue growth 5Y9.78%
Sales Q2Q%-12.73%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
SYPR Yearly Revenue VS EstimatesSYPR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M
SYPR Yearly EPS VS EstimatesSYPR Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2017 2018 2019 0 -0.5 -1 -1.5

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

SYPR reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
SYPR Price Earnings VS Forward Price EarningsSYPR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, SYPR is valued a bit more expensive than 70.00% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 13
SYPR Per share dataSYPR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 2 3 4 5

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for SYPR!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

SYPRIS SOLUTIONS INC

NASDAQ:SYPR (8/22/2025, 8:00:00 PM)

After market: 1.87 +0.01 (+0.54%)

1.86

+0.03 (+1.64%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupAutomobiles & Components
GICS IndustryAutomobile Components
Earnings (Last)08-19 2025-08-19
Earnings (Next)11-10 2025-11-10
Inst Owners17.53%
Inst Owner Change-1.23%
Ins Owners30.44%
Ins Owner Change-0.72%
Market Cap42.84M
Analysts43.33
Price TargetN/A
Short Float %3.22%
Short Ratio9.78
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.33
P/FCF N/A
P/OCF N/A
P/B 2.25
P/tB 2.25
EV/EBITDA 13
EPS(TTM)-0.1
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.33
FCFYN/A
OCF(TTM)-0.3
OCFYN/A
SpS5.63
BVpS0.83
TBVpS0.83
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -2.29%
ROE -12.79%
ROCE 3.32%
ROIC 2.59%
ROICexc 2.59%
ROICexgc 2.59%
OM 1.13%
PM (TTM) N/A
GM 12.91%
FCFM N/A
ROA(3y)-1.68%
ROA(5y)0.28%
ROE(3y)-9.48%
ROE(5y)-0.38%
ROIC(3y)2.71%
ROIC(5y)2.33%
ROICexc(3y)3.62%
ROICexc(5y)3.11%
ROICexgc(3y)3.62%
ROICexgc(5y)3.11%
ROCE(3y)3.47%
ROCE(5y)2.97%
ROICexcg growth 3Y19.25%
ROICexcg growth 5YN/A
ROICexc growth 3Y19.25%
ROICexc growth 5YN/A
OM growth 3Y2.33%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.59%
GM growth 5Y4.73%
F-Score4
Asset Turnover1.22
Health
Industry RankSector Rank
Debt/Equity 0.61
Debt/FCF N/A
Debt/EBITDA 2.63
Cap/Depr 25.09%
Cap/Sales 0.56%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.37
Quick Ratio 0.42
Altman-Z 0.21
F-Score4
WACC8.98%
ROIC/WACC0.29
Cap/Depr(3y)66%
Cap/Depr(5y)73.2%
Cap/Sales(3y)1.7%
Cap/Sales(5y)1.97%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)44.51%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-25.92%
Revenue growth 3Y12.9%
Revenue growth 5Y9.78%
Sales Q2Q%-12.73%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y399.8%
EBIT growth 3Y15.53%
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-145.52%
FCF growth 3Y-13.47%
FCF growth 5YN/A
OCF growth 1Y-135.4%
OCF growth 3Y-22.16%
OCF growth 5YN/A